Inflammation in common variable immunodeficiency is associated with a distinct CD8+ response to cytomegalovirus

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages

  Marashi, Sayed Mahdi ^a   Raeiszadeh, Mohammad ^a   Workman, Sarita ^a   Rahbar, Afsar ^c   Soderberg Naucler, Cecilia ^c   Klenerman, Paul ^d   Chee, Ronnie ^b   Webster, A David ^b   Milne, Richard S B ^a   Emery, Vincent C ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

common variable immunodeficiency; Cytomegalovirus; inflammation

Indexed keywords

5' NUCLEOTIDASE; CYTOMEGALOVIRUS ANTIGEN PP65; INFLIXIMAB; KI 67 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CD8+ T LYMPHOCYTE; COMMON VARIABLE IMMUNODEFICIENCY; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 79957793651     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.04.001     Document Type: Article

References (41)

1. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet 2008;372:489-502.
2. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009;145:709-27.
3. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48. (Pubitemid 29315984)
4. Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin North Am 2008;28:367-86, ix-x.
5. Webster ADB. Common variable immunodeficiency. In: C Roifmann, editor. Immunology and allergy clinics of North America. Philadelphia (PA): Elsevier; 2001. pp. 1-21.
6. Halliday E, Winkelstein J, Webster AD. Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality. J Infect 2003;46:1-8. (Pubitemid 37266021)
7. Yap PL,McOmishF,WebsterAD,HammarstromL,Smith CI, Bjorkander J, et al.HepatitisCvirus transmission by intravenousimmunoglobulin. J Hepatol 1994;21:455-60.
8. Klenerman P. Commentary: T cells get by with a little help from their friends. Eur J Immunol 2004;34:313-6. (Pubitemid 39255941)
9. Lilley BN, Ploegh HL. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond. Immunol Rev 2005;207:126-44. (Pubitemid 41415013)
10. Mocarski ES Jr. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 2002;10:332-9.
11. Raeiszadeh M, Kopycinski J, Paston S, Diss T, Lowdell M, Hardy G, et al. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol 2006;141:234-42. (Pubitemid 44581338)
12. Chapel H, Geha R, Rosen F. Primary immunodeficiency diseases: an update. Clin Exp Immunol 2003;132:9-15. (Pubitemid 36418900)
13. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007;120:776-94.
14. Webster ADB, Amlot P. Granulomas in primary immunodeficiency. In: James DG, Zumla A, editors. The granulomatous disorders. Cambridge (UK): Cambridge Univ Pr; 1999. pp. 387-98.
15. Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A, et al. Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant 2008;8: 2590-9.
16. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78. (Pubitemid 37324571)
17. Hutchinson SL, Wooldridge L, Tafuro S, Laugel B, Glick M, Boulter JM, et al. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J Biol Chem 2003;278:24285-93. (Pubitemid 37548578)
18. Wooldridge L, Lissina A, Vernazza J, Gostick E, Laugel B, Hutchinson SL, et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region. Eur J Immunol 2007;37:1323-33. (Pubitemid 46925316)
19. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994;171:131-7. (Pubitemid 24140219)
20. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002;360:1557-63. (Pubitemid 35356371)
21. Soderberg-Naucler C. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008;41:218-23.
22. Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2007;150:306-11. (Pubitemid 47609561)
23. Walker LJ, Sewell AK, Klenerman P. T cell sensitivity and the outcome of viral infection. Clin Exp Immunol 2010;159:245-55.
24. Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008;48: 74-82. (Pubitemid 350191989)
25. Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ, et al. Sarcoidosis and common variable immunodeficiency: report of 8 cases and review of the literature. Medicine (Baltimore) 1996;75:251-61. (Pubitemid 26337845)
26. Wright JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990; 76:2046-51.
27. Serrano D, Becker K, Cunningham-Rundles C, Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin Immunol 2000;97:248-58.
28. Jaffe JS, Strober W, Sneller MC. Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 1993; 82:192-201. (Pubitemid 23188764)
29. Carbone J, Sarmiento E, Micheloud D, Rodriguez-Molina J, Fernandez-Cruz E. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings. Allergol Immunopathol (Madr) 2006;34: 131-5.
30. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, et al. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin Exp Immunol 2004;138:278-89. (Pubitemid 39472445)
31. Jang EY, Park SY, Lee EJ, Song EH, Chong YP, Lee SO, et al. Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis 2009;48:e121-4.
32. Samata M, Harkines L, Klemm K, Britt W, Cobbs C. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 2003;170:998-1002. (Pubitemid 36999620)
33. Derby MA, Snyder JT, Tse R, Alexander-Miller MA, Berzofsky JA. An abrupt and concordant initiation of apoptosis: antigen-dependent death of CD8+ CTL. Eur J Immunol 2001;31:2951-9. (Pubitemid 32994547)
34. Anderton SM. Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology 2001;104:367-76. (Pubitemid 34037828)
35. Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med 1996;184:485-92. (Pubitemid 26324102)
36. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR. Multiple-cytokine- producing antiviral CD4 T cells are functionally superior to single-cytokineproducing cells. J Virol 2007;81:8468-76. (Pubitemid 47242819)
37. Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006;203:2865-77. (Pubitemid 46026164)
38. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto- 5′-nucleotidase (CD73). Purinergic Signal 2006;2:351-60.
39. Grunewald JK, Ridley AJ. CD73 represses pro-inflammatory responses in human endothelial cells. J Inflamm (Lond) 2010;7:10.
40. Yegutkin GG, Hytonen J, Samburski SS, Yrjanainen H, Jalkanen S, Viljanen MK. Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice. J Immunol 2010;184:5112-20.
41. Thatayatikom A, Thatayatikom S, White AJ. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005;95:293-300. (Pubitemid 41376801)